Editorial: Global excellence in natural products for endocrine disorders

Front Endocrinol (Lausanne). 2023 Nov 28:14:1325355. doi: 10.3389/fendo.2023.1325355. eCollection 2023.

Authors

Helena Malvezzi¹, Vineet K Maurya², Eileen Brantley³, Lokesh Kumar⁴

Affiliations

¹ Hospital Israelita Albert Einstein, São Paulo, Brazil.
² Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.
³ Division of Pharmacology, School of Medicine, Loma Linda University, Loma Linda, CA, United States.
⁴ GenusPlc, ABS Global, Windsor, WI, United States.

No abstract available

Keywords: diabetes; glucocorticoid receptors; hemoglobin A1c; hormonal imbalances; metformin.

Publication types

Editorial

MeSH terms

Biological Products* / therapeutic use
Hypoglycemic Agents
Metformin*

Substances

Biological Products
Hypoglycemic Agents
Metformin

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.